Study of NGM438 as Monotherapy and in Combination With Pembrolizumab in Advanced or Metastatic Solid Tumors
NGM Biopharmaceuticals, Inc
NGM Biopharmaceuticals, Inc
R-Pharm
R-Pharm
AO GENERIUM
RemeGen Co., Ltd.
TopAlliance Biosciences
JS InnoPharm, LLC
Provectus Pharmaceuticals
OncoResponse, Inc.
Biocad
Biocad
Kineta Inc.
NovalGen Ltd.
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
PrimeVax Immuno-Oncology Inc.
Namida Lab
Shanghai Kechow Pharma, Inc.
Qilu Pharmaceutical Co., Ltd.
Shanghai Kanda Biotechnology Co., Ltd.
OncoSec Medical Incorporated
Biocad
Biocad
Provectus Pharmaceuticals
Revolution Medicines, Inc.
Taiga Biotechnologies, Inc.
Philogen S.p.A.
Infinity Pharmaceuticals, Inc.
TScan Therapeutics, Inc.
PersonGen BioTherapeutics (Suzhou) Co., Ltd.
Pierre Fabre Medicament
Beijing Immunochina Medical Science & Technology Co., Ltd.
CureVac
Bristol-Myers Squibb
Ella Therapeutics Ltd
Asylia Diagnostics BV
Taizhou HoudeAoke Biomedical Co., Ltd.
Taizhou Hanzhong biomedical co. LTD
SpeciCare
Biocad
Ardigen
MultiVir, Inc.
OrienGene Biotechnology Ltd.
Shenzhen BinDeBio Ltd.
Timmune Biotech Inc.
Ardigen
Quantgene Inc.
Biocad
Elucid Labs Inc.
Biocad
Threshold Pharmaceuticals